Page 1 | Search Results | Blood | American Society of Hematology

1-9 of 9

Sort by

Sort Order Select

Journal Articles

Caphosol Mouth Rinse Diminishes Oral Mucositis In Allo-HSCT Recipients.

Miroslaw Markiewicz, MD, PhD, Dzierzak Mietla Monika, MD, Patrycja Zielinska, Tomasz Kruzel, MD, Tomasz Czerw, MD, Slawomira Kyrcz-Krzemien, Prof, MD, PhD

Blood (2010) 116 (21): 3498.

https://doi.org/10.1182/blood.V116.21.3498.3498

Published: 2010

Journal Articles

DynaChip Anti-HLA Antibody Analysis In Sera of Patients Following Allo-HSCT From HLA-Mismatched Unrelated Donors.

Miroslaw Markiewicz, MD, PhD, Urszula Siekiera, Tomasz Kruzel, MD, Monika Dzierzak-Mietla, MD, Patrycja Zielinska, MD, Slawomira Kyrcz-Krzemien, Prof, MD, PhD

Blood (2010) 116 (21): 4575.

https://doi.org/10.1182/blood.V116.21.4575.4575

Published: 2010

Journal Articles

Treosulfan-Based Reduced Toxicity Regimen Prior to Allogeneic Hematopoietic Cell Transplantation in Non-Malignant Disorders.

Jerzy Wojnar, MD, Sebastian Giebel, MD, Miroslaw Markiewicz, MD, Malgorzata Krawczyk-Kulis, MD, Iwona Wylezol, MD, Beata Stella-Holowiecka, MD, Tomasz Kruzel, MD, Jerzy Holowiecki

Blood (2006) 108 (11): 5245.

https://doi.org/10.1182/blood.V108.11.5245.5245

Published: 2006

Journal Articles

Impaired Survival after Unrelated Hematopoietic Stem Cell Transplantation from KIR2DS1 and KIR2DS2 Positive Donors.

Sebastian Giebel, MD, Tomasz Czerw, MD, Izabela Nowak, PhD, Jerzy Wojnar, MD, Tomasz Kruzel, MD, Joanna Dziaczkowska, PhD, Miroslaw Markiewicz, MD, Aleksandra Holowiecka-Goral, MD, Agnieszka Karolczyk, PhD, Iwona Wylezol, MD, Piotr Kusnierczyk, PhD, Jerzy Holowiecki

Blood (2006) 108 (11): 3113.

https://doi.org/10.1182/blood.V108.11.3113.3113

Published: 2006

Journal Articles

Impact of Activating Killer Immunoglobulin-Receptor Genotype of the Donor on Outcome of Unrelated Donor - Hematopoietic Stem Cell Transplantation.

Sebastian Giebel, MD, Izabela Nowak, PhD, Tomasz Kruzel, MD, Jerzy Wojnar, MD, Miroslaw Markiewicz, MD, Joanna Dziaczkowska, MD, Iwona Wylezol, MD, Malgorzata Krawczyk-Kulis, MD, Renata Bloch, PhD, Tomasz Czerw, MD, Agnieszka Karolczyk, PhD, Piotr Kusnierczyk, PhD, Jerzy Holowiecki

Blood (2005) 106 (11): 5206.

https://doi.org/10.1182/blood.V106.11.5206.5206

Published: 2005

Journal Articles

Treosulfan + Fludarabine +/− Thymoglobulin - An Effective Low Toxicity Conditioning Regimen for Allogeneic Hematopoietic Stem Cell Transplantation in Chronic Myeloid Leukemia.

Jerzy Holowiecki, Sebastian Giebel, MD, Jerzy Wojnar, MD, Malgorzata Krawczyk-Kulis, MD, Iwona Wylezol, MD, Miroslaw Markiewicz, MD, Tomasz Kruzel, MD, Aleksandra Holowiecka-Goral, MD, Malgorzata Kopera, MD

Blood (2005) 106 (11): 5309.

https://doi.org/10.1182/blood.V106.11.5309.5309

Published: 2005

Journal Articles

Gleevec Therapy in Advanced Phases of the Cml - Polish Study Report.

Bernadeta B. Ceglarek, MD.PhD, Lech J. Konopka, MD.PhD, Anna Sikorska, MD.PhD, Kinga Kos, MD, Jerzy Holowiecki, MD.PhD, Malgorzata Kopera, MD.PhD, Grazyna Bober, MD.PhD, Tomasz Kruzel, MD., Barbara Pienkowska-Grela, MD.PhD, Renata Woroniecka, Msc., Joanna Rygier, Msc

Blood (2004) 104 (11): 4701.

https://doi.org/10.1182/blood.V104.11.4701.4701

Published: 2004

Journal Articles

Treosulfan-Based Myeloablative Conditioning Prior to Allogeneic Hematopoietic Cell Transplantation Is Associated with Reduced Toxicity without Increased Risk of Relapse.

Sebastian Giebel, MD, Jerzy Wojnar, MD, Malgorzata Krawczyk-Kulis, MD, Iwona Wylezol, MD, Miroslaw Markiewicz, MD, Tomasz Kruzel, MD, Jerzy Holowiecki, MD

Blood (2004) 104 (11): 1152.

https://doi.org/10.1182/blood.V104.11.1152.1152

Published: 2004

Journal Articles

Treosulfan/Fludarabine - a Low Toxicity but Myeloablative Conditioning for Allogeneic Hematopoietic Stem Cell Transplantation in Chronic Myeloid Leukemia.

Jerzy Holowiecki, Sebastian Giebel, MD, Jerzy Wojnar, MD, Malgorzata Krawczyk-Kulis, MD, Iwona Wylezol, MD, Tomasz Kruzel, MD, Miroslaw Markiewicz, MD

Blood (2004) 104 (11): 1022.

https://doi.org/10.1182/blood.V104.11.1022.1022

Published: 2004

NARROW

Caphosol Mouth Rinse Diminishes Oral Mucositis In Allo-HSCT Recipients.

DynaChip Anti-HLA Antibody Analysis In Sera of Patients Following Allo-HSCT From HLA-Mismatched Unrelated Donors.

Treosulfan-Based Reduced Toxicity Regimen Prior to Allogeneic Hematopoietic Cell Transplantation in Non-Malignant Disorders.

Impaired Survival after Unrelated Hematopoietic Stem Cell Transplantation from KIR2DS1 and KIR2DS2 Positive Donors.

Impact of Activating Killer Immunoglobulin-Receptor Genotype of the Donor on Outcome of Unrelated Donor - Hematopoietic Stem Cell Transplantation.

Treosulfan + Fludarabine +/− Thymoglobulin - An Effective Low Toxicity Conditioning Regimen for Allogeneic Hematopoietic Stem Cell Transplantation in Chronic Myeloid Leukemia.

Gleevec Therapy in Advanced Phases of the Cml - Polish Study Report.

Treosulfan-Based Myeloablative Conditioning Prior to Allogeneic Hematopoietic Cell Transplantation Is Associated with Reduced Toxicity without Increased Risk of Relapse.

Treosulfan/Fludarabine - a Low Toxicity but Myeloablative Conditioning for Allogeneic Hematopoietic Stem Cell Transplantation in Chronic Myeloid Leukemia.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only